Viewing StudyNCT00258388



Ignite Creation Date: 2024-05-05 @ 12:09 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00258388
Status: COMPLETED
Last Update Posted: 2023-08-04
First Post: 2005-11-22

Brief Title: Docetaxel and Prednisone WithOut OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
Sponsor: NCIC Clinical Trials Group
Organization: Canadian Cancer Trials Group

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords:
Name View
stage IV prostate cancer View
adenocarcinoma of the prostate View
recurrent prostate cancer View